
Best Practices in Parkinson Disease Psychosis: A Medscape Podcast Series
by Medscape
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇳🇿NZ · Medicine#4110K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
7K to 21K🎙 Biweekly cadence·5 episodes·Long inactive - Monthly Reach
Unique listeners across all episodes (30 days)
10K to 30K🇳🇿100% - Active Followers
Loyal subscribers who consistently listen
3K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Episode 5 – Getting Current on Data for the Management of Parkinson Disease Psychosis and Parkinson Disease Dementia
Mar 27, 2023
Unknown duration
Episode 4 – Parkinson Disease Psychosis in the Long-Term Care Setting
Feb 21, 2023
Unknown duration
Episode 3 – Therapeutic Decision Making in Parkinson Disease Psychosis
Dec 1, 2022
Unknown duration
Episode 2 – Making the Case for a Diagnosis of PDP
Oct 20, 2022
Unknown duration
Episode 1 – Making Parkinson Disease Psychosis a Priority in Practice
Sep 28, 2022
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 3/27/23 | ![]() Episode 5 – Getting Current on Data for the Management of Parkinson Disease Psychosis and Parkinson Disease Dementia | Which antipsychotics are best for managing Parkinson disease psychosis (PDP)? Drs Grossberg and Isaacson review clinical data for PDP treatments. Credit available for this activity expires: [3/27/2024] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990125?ecd=bdc_podcast_libsyn_mscpedu | — | |
| 2/21/23 | ![]() Episode 4 – Parkinson Disease Psychosis in the Long-Term Care Setting | What should be considered when managing Parkinson disease psychosis (PDP) in long-term care? Drs Grossberg and Patel provide suggestions for screening and management. Credit available for this activity expires: 2/16/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988290?ecd=bdc_podcast_libsyn_mscpedu | — | |
| 12/1/22 | ![]() Episode 3 – Therapeutic Decision Making in Parkinson Disease Psychosis | When is it time to treat Parkinson disease psychosis (PDP)? What are the options? Drs Grossberg and Pahwa discuss considerations in management. Credit available for this activity expires: 11/30/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/984739?ecd=bdc_podcast_libsyn_mscpedu | — | |
| 10/20/22 | ![]() Episode 2 – Making the Case for a Diagnosis of PDP | Are you routinely asking your patients with Parkinson disease (PD) questions about auditory or visual disturbances? Drs Grossberg and Lew discuss routine assessment approaches for timely recognition of psychosis. Credit available for this activity expires: 10/20/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982718?src=mkm_podcast_series_982718 | — | |
| 9/28/22 | ![]() Episode 1 – Making Parkinson Disease Psychosis a Priority in Practice | What does Parkinson disease psychosis (PDP) look like? How does it affect patients and caregivers? Drs Grossberg and Larson discuss the symptoms and burden of PDP. Credit available for this activity expires: 9/22/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/981188?src=mkm_podcast_series_981188 | — |
Showing 5 of 5
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.
